Literature DB >> 12538480

Hepatocyte growth factor and c-Met in cervical intraepithelial neoplasia: overexpression of proteins associated with oncogenic human papillomavirus and human immunodeficiency virus.

Francine Walker1, Stéphanie Kermorgant, Emile Daraï, Patrick Madelenat, Anne Claude Cremieux, Dominique Hénin, Thérèse Lehy.   

Abstract

PURPOSE: High prevalence of squamous cervical intraepithelial neoplasia (CIN) linked to oncogenic human papillomavirus (HPV) exits in HIV-infected women. Hepatocyte growth factor (HGF) and its receptor, c-Met, promote cell proliferation and are involved in tumor progression. Nothing is yet known about their expression in low- and high-grade CIN. Therefore, the expression, localization, and behavior of HGF and c-Met in normal and dysplastic cervical epithelium were investigated. EXPERIMENTAL
DESIGN: We studied normal cervical mucosa from 10 healthy women, and low- and high-grade cervical lesions, uninfected (condyloma acuminata) or infected with oncogenic HPVs, from 40 HIV-negative and 48 HIV-positive women, using in situ molecular techniques, immunocytochemistry and morphoquantitative methods.
RESULTS: In 154 oncogenic HPV-infected CIN encountered in biopsy samples, the total number of epithelial cell layers increased significantly during lesion progression. This number was significantly higher in HIV-positive than in HIV-negative women for CIN1 and CIN2 (P < 0.025 to P < 0.01). In HIV-negative women, the number and percentage of HGF and c-Met immunostained cell layers, and the intensity of immunostaining were enhanced in oncogenic HPV-infected lesions as compared with normal mucosa and condyloma acuminata. The latter parameters were significantly higher in tissues of HIV-positive women (oncogenic HPV-infected CIN1 and CIN2, normal-appearing mucosa contiguous to CIN, condyloma acuminata) than in the corresponding tissues of HIV-negative women (P < 0.025 to P < 0.0001).
CONCLUSIONS: Overexpression of HGF/c-Met complex strongly correlates with oncogenic HPV and HIV infection. This overexpressed complex may stimulate cell proliferation in condyloma acuminata and participate in tumor progression in oncogenic HPV-infected lesions.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12538480

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  14 in total

1.  Modulation of hepatocyte growth factor secretion in human female reproductive tract stromal fibroblasts by poly (I:C) and estradiol.

Authors:  Kimberly D Coleman; Mimi Ghosh; Sarah G Crist; Jacqueline A Wright; Richard M Rossoll; Charles R Wira; John V Fahey
Journal:  Am J Reprod Immunol       Date:  2011-08-23       Impact factor: 3.886

Review 2.  The Interaction Between Human Papillomaviruses and the Stromal Microenvironment.

Authors:  B Woodby; M Scott; J Bodily
Journal:  Prog Mol Biol Transl Sci       Date:  2016-10-11       Impact factor: 3.622

3.  Human papillomavirus oncoprotein E6 upregulates c-Met through p53 downregulation.

Authors:  Guoqing Qian; Dongsheng Wang; Kelly R Magliocca; Zhongliang Hu; Sreenivas Nannapaneni; Sungjin Kim; Zhengjia Chen; Shi-Yong Sun; Dong M Shin; Nabil F Saba; Zhuo G Chen
Journal:  Eur J Cancer       Date:  2016-07-22       Impact factor: 9.162

4.  Human papillomavirus type 16 E5-mediated upregulation of Met in human keratinocytes.

Authors:  Matthew L Scott; David T Coleman; Kinsey C Kelly; Jennifer L Carroll; Brittany Woodby; William K Songock; James A Cardelli; Jason M Bodily
Journal:  Virology       Date:  2018-03-31       Impact factor: 3.616

Review 5.  MET: a promising anticancer therapeutic target.

Authors:  Solange Peters; Alex A Adjei
Journal:  Nat Rev Clin Oncol       Date:  2012-05-08       Impact factor: 66.675

6.  Pathway profiling and rational trial design for studies in advanced stage cervical carcinoma: a review and a perspective.

Authors:  Susy M E Scholl; Gemma Kenter; Christian Kurzeder; Philippe Beuzeboc
Journal:  ISRN Oncol       Date:  2011-07-06

Review 7.  Breast cancer in low-middle income countries: abnormality in splicing and lack of targeted treatment options.

Authors:  Flavia Zita Francies; Rodney Hull; Richard Khanyile; Zodwa Dlamini
Journal:  Am J Cancer Res       Date:  2020-05-01       Impact factor: 5.942

8.  MET receptor is a potential therapeutic target in high grade cervical cancer.

Authors:  Katarzyna Miekus; Marta Pawlowska; Małgorzata Sekuła; Grazyna Drabik; Zbigniew Madeja; Dariusz Adamek; Marcin Majka
Journal:  Oncotarget       Date:  2015-04-30

9.  Expression of c-Met Is Different along the Location and Associated with Lymph Node Metastasis of Head and Neck Carcinoma.

Authors:  Ji-Young Choe; Ji Yun Yun; Soo-Jeong Nam; Ji Eun Kim
Journal:  Korean J Pathol       Date:  2012-12-26

10.  Prognostic assessment of hypoxia and metabolic markers in cervical cancer using automated digital image analysis of immunohistochemistry.

Authors:  Bo Wook Kim; Hanbyoul Cho; Joon-Yong Chung; Catherine Conway; Kris Ylaya; Jae-Hoon Kim; Stephen M Hewitt
Journal:  J Transl Med       Date:  2013-08-08       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.